Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02538822
Other study ID # 1408061
Secondary ID ANSM
Status Terminated
Phase N/A
First received
Last updated
Start date October 6, 2014
Est. completion date September 16, 2018

Study information

Verified date January 2020
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aneurysms of the thoracic ascending aorta are a serious pathology which may threatens life by rupture or dissection. Their incidence is estimated at 10.4 per 100,000 people. At present, the only parameter for assessing the risk of complication is the maximum diameter of the aneurysm. The only way to avoid a complication is a surgical replacement of the aneurysmal aorta by a prosthetic tube. This procedure is performed by sternotomy and with extracorporeal circulation and its death rate ranges between 3% and 5%. Surgical repair is indicated when the diameter of the aneurysm exceeds 5.5 cm for degenerative atheromatous aneurysms or 5 cm in a patient with genetic disorder of connective tissue (Marfan disease or Ehlers-Danlos syndrome). However, there are aneurysms with diameter greater than the surgical threshold which remain stable. Conversely, complications have been described for aneurysms less than 4.5 cm in diameter. The criterion of diameter appears therefore as inadequate to assess the risk of complication of an aneurysm of the ascending aorta.Multiple methods have been described in the literature. One of them relies on in vitro mechanical testing on healthy or aneurysmal tissue. Another method is the vivo analysis from imaging (CT, MRI or ultrasound). So far, no algorithm is robust enough for predicting the risk of complication better than the universally used criterion of diameter. The pathophysiology of these aneurysms has also been explored from histological studies. The investigators know that the microstructure of the aortic wall of an aneurysm is deteriorated with a degradation of elastin fibers and collagen that determine to a large extent its biomechanical behavior. Histological analysis appears inseparable from biomechanical analysis.


Recruitment information / eligibility

Status Terminated
Enrollment 31
Est. completion date September 16, 2018
Est. primary completion date September 16, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diameter of ATA exceeds 5.5 cm - Diameter of ATA exceeds 5 cm in a patient with genetic disorder of connective tissue (Marfan disease or Ehlers-Danlos syndrome) - Diameter of ATA exceeds 5 cm in a patient with aortic valvulopathy - Written consent Exclusion Criteria: - Contra-indication to MRI - Chronic insufficiency kidney

Study Design


Related Conditions & MeSH terms


Intervention

Device:
dynamic imaging
In vivo study of biomechanical behavior of ATA from preoperative dynamic imaging : dynamic CT-scan and 4D-magnetic resonance imaging (MRI)
mechanical testing
In vitro study of with mechanical inflation testing of ATA tissue harvested during surgery.

Locations

Country Name City State
France CHU Saint-Etienne Saint-Etienne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between index of risk of the rupture and in vivo physiological elasticity. The index of risk of rupture is a composite measure :
an in vivo study of biomechanical behavior of aneurysmal aorta from preoperative dynamic imaging (dynamic CT-scan and 4D-MRI). It will determine the maximum stress borne by the aortic wall and its physiological elasticity.
an in vitro study with mechanical inflation testing of aneurysmal aortic tissue harvested during surgery. These tests will be conducted up to rupture and will bring results on the elasticity of the aortic wall of the aneurysm and its mode of failure.
finally, a histological analysis, with measurement of elastin and collagen content.
The physiological elasticity is measured from MRI
day 1
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02777593 - Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 N/A
Completed NCT02876263 - Noninvasive Neuromonitoring of Surgery of the Thoracic Aorta N/A
Completed NCT04930172 - TOtal tRansfemoral branCHed endovasCular tHoracoabdominal Aortic Repair Registry
Completed NCT03207568 - RE-GENERATION: The Safety and Performance of the Relay Pro and Relay NBS Pro Stent-graft Devices in the European Union (EU) N/A
Recruiting NCT03010514 - A Registry Study on Genetics and Biomarkers of Thoracic Aortic Aneurysm/Dissection N/A
Completed NCT02266342 - GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry
Completed NCT00757003 - To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease Phase 3
Recruiting NCT03574311 - Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery Phase 4
Suspended NCT03410420 - Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride Phase 1
Recruiting NCT05703893 - Investigation of the Neurovegetative Pattern in Patients With Thoracic Aortic Aneurysms (TAA)
Enrolling by invitation NCT05800743 - Evaluation of the GORE® Ascending Stent Graft N/A
Completed NCT02253082 - Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28) Phase 4
Recruiting NCT02323581 - Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts N/A
Active, not recruiting NCT03414866 - Thoraflex Hybrid Post-Market Study
Recruiting NCT01985906 - Safety and Efficacy of Multiple Overlapping Uncovered Stents for Pararenal Aortic Aneurysm Repair N/A
Active, not recruiting NCT02818972 - RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers N/A
Completed NCT03479164 - Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms N/A
Completed NCT01775046 - Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases (VALIANT CAPTIVIA France)
Recruiting NCT04814238 - Minimally Invasive Aortic Root and Aorta surGery rEgistry
Completed NCT01756911 - Evaluation of the Safety and Efficacy of the Multilayer Stent N/A